Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study.

Li, Zixiong; Han, Ning; Ren, Xueying; Zhang, Yuanjing; Chu, Xiaoyuan

Li, Zixiong; Han, Ning; Ren, Xueying; Zhang, Yuanjing; Chu, Xiaoyuan.

Afiliação

Li Z; Department of Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Han N; Department of Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Ren X; Department of Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Zhang Y; Department of Infection, Changzheng Hospital, Naval Medical University, Shanghai, China.
Chu X; Department of Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.

Front Oncol ; 12: 833884, 2022.

Article em En | MEDLINE | ID: mdl-35433466

Palavras-chave

PD-1; hepatocellular carcinoma; locoregional therapies; recurrence; systemic therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google